Special Issue of "New Trends in Virtual Screening", Edited by Prof. Renxiao Wang, is Just Published On-line

The "New Trends in Virtual Screening" special issue edited by Professor Renxiao Wang from the Department of Medicinal C...

Xiaoyan Shen group disclosed that Sorting Nexin 10 (SNX10) plays an essential role in atherosclerosis

Cardiovascular disease (CVD) is a leading cause of death and loss of productive life years worldwide1. Atherosclerosis ...

Advance in Target-drug-delivery for Cerebral Ischemia

A novel liposome-leukocytes combination delivery system was designed for ischemic stroke target therapy. The study was ...

A Novel PGAM1 Allosteric Inhibitor Discovered by Lu Zhou's lab

Recently, Lu Zhou's lab from School of Pharmacy, Fudan University, has published a paper entitled "A novel allosteric i...

Recent progress of Wei Lu’s research group in the development of theranostic formulation for cancer photodynamic immunotherapy

Recently, Professor Wei Lu from School of Pharmacy, Fudan University, has designed a new theranostic preparation using ...

Advance in Noninvasive Intraocular Gene Delivery -Flexible octopus-like vectors enabled noninvasive intraocular gene delivery

Vision has profound influence on the quality of life. Up to now, the number of visually impaired patients worldwide is ...

Recent progress of Wei Lu’s research group in the field of development of adjuvant formulation for cancer immunotherapy

Recently, Professor Wei Lu from School of Pharmacy, Fudan University, has used biomimetic technology to prepare an adju...

Novel approach in treating acute ischemic stroke

With the support of National Science Fund for Distinguished Young Scholars and National Natural Science Foundation of C...

The team of Professor Xiaoyan Shen from the School of Pharmacy, Fudan University made new progress in the field of autophagy and colorectal cancer

Recently, the team of Professor Xiaoyan Shen (School of Pharmacy, Fudan University) in collaboration with the team of Z...

Recent Progress of Professor Di Zhu’s Group in the Field of Colorectal Cancer Immunotherapy

Recently, Di Zhu, professor at the School of Pharmacy, and Yuxiong Feng, professor at Zhejiang University, have made ne...

Professor Jun Chen’s Group Made Novel Progress in Sequentially Modulating Tumor Microenvironment and Interfering with Cancer Cell Target

The limited chemotherapy effect of pancreatic cancer is related to its unique and complex tumor microenvironment (TME)....

Professor Jun Chen’s Group Made Novel Progress in Pre-metastatic Niche Modulation and Tumor Metastasis Suppression

Metastasis is the major cause of high mortality in cancer patients, thus metastasis suppression is the key and most cha...

Recent progress of Professor Wei Lu’s research group in the field of intraoperative image-guided photothermal removal of small tumors

Recently, Professor Wei Lu of the School of Pharmacy, Fudan University and Professor Zeyu Xiao of the School of Medicin...

A novel biomimetic nanomedicine for effective antiglioma therapy

Teams from Fudan University (Prof. Weiyue Lu’s lab) and University of California, San Diego (Prof. Liangfang Zhang’s ...

A Dual-Bioresponsive Drug Delivery Depot for Combination of Epigenetic Modulation and Immune Checkpoint Blockade

Epigenetic alteration like DNA hypermethylation plays a pivotal role in immune evasion of cancer cells during tumorigen...

Professor Chen Jiang’s group developed a novel strategy for neurodegenerative disease treatment

Recently, Professor Chen Jiang’s group from Fudan University School of Pharmacy developed a polymeric micelle drug del...

Professor Chen Jiang’s group made great progress in cancer immunotherapy

Recently, Professor Chen Jiang’s group from Fudan University School of Pharmacy developed a new type of prodrug-loaded...

Professor Chen Jiang’s Group of Fudan University Made New Progress in Targeted Drug Delivery and Treatment of Primary and Metastatic TNBC

Triple-negative breast cancer (TNBC) is an extremely hard-to-treat subtype (~15%) of breast cancer. As TNBC lacks expre...

A breakthrough in bortezomib-nanomedicine

Recently, the research about a novel smart anti-tumor nanomedicine was published online in Advanced Functional Material...

Professor Chen Jiang's Group of Fudan University Made New Progress in Targeted Drug Delivery and Treatment of Primary and Metastatic TNBC

Triple-negative breast cancer (TNBC) is an extremely hard-to-treat subtype (~15%) of breast cancer. As TNBC lacks expre...